Clinician awareness of drug costs
HIV transmission elimination
Increased awareness of the actual cost of HIV treatments and how local prescribing impacts on cost will support clinicians and teams reflect on treatment decisions. Contract prices for individual agents are commercially sensitive, and are also subject to change owing to tendering and negotiation. Therefore this information needs to be shared respecting commercial confidence and updated regularly.
The following information should be available to prescribers:
- ART regimens prescribed on a regular basis.
- Cost of individual combinations including cost differences for acute and community prescribing.
- Reflection on the impact of treatment decisions on patients including: adherence, engagement in care, virological control and side effects.
- Regular reporting from NSS procurement to the SHPN HIV Clinical Leads and HIV Pharmacists on changes in ART pricing detailed by methods of dispensing.